Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-25 Sale |
2023-04-27 5:00 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
6,130 | $165 | $1,011,450 | 47,588 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-19 5:00 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
7,499 | $161.67 | $1,212,338 | 35,330 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 5:00 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
15,002 | $160.03 | $2,400,770 | 42,829 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:07 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
15,003 | $155 | $2,325,465 | 42,829 (Direct) |
View |
| 2023-02-21 Sale |
2023-02-21 6:12 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
15,321 | $151.04 | $2,314,119 | 83,505 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-01 6:11 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
6,484 | $148.28 | $961,467 | 17,876 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-14 5:01 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
6,458 | $125.85 | $812,739 | 0 (Direct) |
View |
| 2021-08-23 Sale |
2021-08-25 6:08 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
13,080 | $120 | $1,569,600 | 11,595 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 8:30 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
8,440 | $108.61 | $916,642 | 17,595 (Direct) |
View |
| 2021-02-22 Sale |
2021-02-24 6:28 pm |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
20,195 | $104.72 | $2,114,732 | 67,948 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-25 Exercise |
2023-04-27 5:00 pm |
2023-02-17 2032-02-16 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
6,130 | $144.54 | 47,588 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 5:00 pm |
2021-02-20 2030-02-19 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
15,002 | $93.5 | 42,829 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-02 5:07 pm |
2020-02-20 2030-02-19 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
15,003 | $93.5 | 42,829 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-02 5:07 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
19,850 | $154.28 | 42,829 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:12 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
57,969 | $0 | 83,505 (Direct) |
View |
| 2023-02-21 Exercise |
2023-02-21 6:12 pm |
2022-02-18 2031-02-17 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS |
15,321 | $105.92 | 83,505 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 6:11 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
11,125 | $149.54 | 17,876 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:42 pm |
2023-02-17 2032-02-16 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
53,873 | $0 | 53,873 (Direct) |
View |
| 2021-12-10 Tax Withholding |
2021-12-14 5:01 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
5,137 | $124.15 | 0 (Direct) |
View |
| 2021-08-23 Exercise |
2021-08-25 6:08 pm |
2019-02-15 2028-02-14 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
7,080 | $0 | 11,595 (Direct) |
View |
| 2021-08-23 Exercise |
2021-08-25 6:08 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
7,080 | $114.36 | 11,595 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 8:30 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
6,716 | $107.74 | 17,595 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 6:28 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
15,003 | $93.5 | 67,948 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 6:28 pm |
2021-02-20 2030-02-19 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
20,195 | $0 | 67,948 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 6:28 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
5,192 | $79.02 | 67,948 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 6:17 pm |
2022-02-18 2031-02-17 |
AbbVie Inc. | ABBV | Sorg Elaine K. SVP, US Commercial Operations |
38,137 | $0 | 55,732 (Direct) |
View |
Ownership |
2020-11-19 4:48 pm |
N/A N/A |
AbbVie Inc. | ABBV | Sorg Elaine K. Sr. V.P., U.S. Commercial Ops. |
0 | $0 | 80,068 (Direct) |
View |